1,116
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Antihyperglycemic Activity of Pongamia pinnata Stem Bark in Diabetic Mice

, &
Pages 900-905 | Accepted 09 May 2008, Published online: 20 Jan 2009

References

  • JA Abdel-Barry, IA Abdel-Hassan, and MH Al-Hakiem. (1997). Hypoglycaemic and antihyperglycaemic effects of Trigonella foenum graecum leaf in normal and alloxan induced diabetic rats. J Ethnopharmacol 58:149–155.
  • R Aiman. (1970). Recent research on indigenous antidiabetic medicinal plants-an overall assessment. Ind J Physiol Pharmacol 14:65–76.
  • S Alam. (2004). Synthesis and studies of antimicrobial activity of lanceolatin B. Acta Chim Slov 51:447–452.
  • LV Asalkar, KK Kakkar, and OJ Chakre. (2000): Second Supplement to Glossary of Indian Medicinal Plants with Active Principles. Part I (A-K) (1965–81). New Delhi, National Institute of Science Communication Publishing, pp. 265–266.
  • SL Badole, SN Shah, NM Patel, PA Thakurdesai, and SL Bodhankar. (2006). Hypoglycemic activity of aqueous extract of Pleurotus pulmonarius in alloxan induced diabetic mice. Pharm Biol 44:421–425.
  • L Bartosikova, J Necas, V Suchy, R Kubinova, D Vesela, L Benes, T Bartosik, J Illek, J Salpachata, J Klusakova, L Bartokova, V Strnadova, P Frana, and J Franova. (2003). Monitoring of antioxidative effect of morine in alloxan induced diabetes in labolatory rat. Acta Vet Brno 72:191–200.
  • CJ Bailey, and C Day. (1989). Traditional treatment for diabetes. Diab Care 12:533–564.
  • AL Catapano. (1997). Antioxidant effect of flavonoids. Angiol 48:39–44.
  • EJ Carcache-Blanco, YH Kang, EJ Park, BN Kardono, LBS Su, S Riswan, HHS Fong, JM Pezzuto, and AD Kinghorn. (2003). Constituents of the stem bark of Pongamia pinnata with the potential to induce quinone reductase. J Nat Prod 66:1197–1202.
  • PG Colman, LI Wang, and KJ Lafferty. (1989): Molecular biology and autoimmunity of type I diabetes mellitus. In: B Drazini, S Melmed, and D LePoith. eds., Molecular and Cellular Biology of Diabetes Mellitus. Insulin Secretion. New York, Alan R. Liss Inc., pp. 125–137.
  • BK Chakravarthy, S Gupta, SS Gambir, and KD Gode. (1980). Pancreatic β cell generation-A novel antidiabetic mechanism of Pterocarpus marsupium Rox. Ind J Pharmacol 12:123–127.
  • S Devipriya, and CS Shyamaladevi. (1999). Protective effect of quercetin in cisplatin induced cell injury in the rat kidney. Ind J Pharmacol 31:422–426.
  • D Giugliano, A Ceriello, and G Paolisso. (1995). Diabetes mellitus, hypertension and cardiovascular disease: Which role for oxidative stress. Metabol 44:363–368.
  • A Jorns, R Munday, M Tiedge, and S Lenzen. (1997). Comparative toxicity of alloxan, N-alkylalloxan and ninhydrin to isolated pancreatic islets in vitro. J Endocrinol 155:283–293.
  • B Kameswararao, R Giri, MM Kesavulu, and C Apparao. (1997). Herbal medicines: In the treatment of diabetes mellitus. Manphar Vaidya Patrika 1:33–35.
  • CP Khare. (2004): Encyclopedia of Indian Medicinal Plants. Springer-Verlag editor. New York, pp 378–379.
  • A Krishnamurthi. (1969): The Wealth of India VIII. New Delhi, Publication and Information Directorate, CSIR.
  • KR Kirtikar, and BD Basu. (1987): Indian Medicinal Plants vol. 1, 2nd edition, E Blatter, JF Caius, and KS Mhaskar. eds., published by Basu LM, Allahabad, India., pp 830–832.
  • CK Kokate. (1991): Practical Pharmacognosy. 3rd eds., published by Jain MK, Vallabh prakashan, New Delhi., pp 107–113.
  • S Koysomboon, IV Altena, S Kato, and Chantrapromma. (2006). Antimicrobacterial flavonoids from Derris indica. Phytochemistry 67:1034–1040.
  • VN Krishna, and ND Grampurohit. (2006). Studies on the alkloids of stembark of Pongamia pinnata Linn. Ind Drugs 43:383–387.
  • M Latha, and L Pari. (2003). Antihyperglycaemic effect of Cassia auriculata in experimental diabetes and its effects on key metabolic enzymes involved in carbohydrated metabolism. Clin Exp Pharmacol Physiol 30:38–43.
  • S Lenzen, and U Panten. (1988). Alloxan: History and mechanism of action. Diabetol 31:337–342.
  • OECD (Organisation for Economic Co-operation and Development) (2001): Guidance Document on Acute Oral Toxicity Testing, Paris, Environment Directorate, OECD, pp. 1–24.
  • VP Pathak, TR Saini, and RN Khanna. (1983). Glabrachalcone-A chromenochalcone from Pongamia glabra seeds. Phytochemistry 22:1303–1304.
  • R Punitha, and S Manoharan. (2006). Antihyperglycemic and antilipidperoxidative effects of Pongamia pinnata (Linn.) Pierre flowers in alloxan induced diabetic rats. J Ethnopharmacol 105:39–46.
  • R Punitha, K Vasudevan, and S Manoharan. (2006). Effect of Pongamia pinnata flowers on blood glucose and oxidative stress in alloxan induced diabetic rats. Ind J Pharmacol 38:62–63.
  • SK Swanston-Flatt, C Day, PR Flatt, BJ Gould, and CJ Bailey. (1989). Glycaemic effects of traditional European plant treatments for diabetes: Studies in normal and streptozotocin diabetic mice. Diab Res 10:69–73.
  • T Szkudelski. (2001). The mechanism of alloxan and streptozotocin action in β cells of the rat pancreas. Physiol Res 50:536–546.
  • SK Talapatra, AK Malik, and B Talapatra. (1982). Isopongaglabol and 6-methoxyiso-pongaglabol, two new hydroxyfuranoflavones from Pongamia glabra. Phytochemistry 21:761–766.
  • T Tanaka, M Iinuma, Y Fujii, K Yuki, and M Mizuno. (1992). Flavonoids in root bark of Pongamia pinnata. Phytochemistry 31:993–998.
  • JT Xie, A Wang, S Mehendale, J Wu, HH Aung, L Dey, S Qiu, and CS Yuan. (2003). Anti-diabetic effects of Gymnema yunnanense extract. Pharmacol Res 47:323–329.
  • H Yin, S Zhang, and J Wu. (2005). Prenylated flavonoids from Pongamia pinnata. Z Naturforsch 60b:356–358.
  • H Yin, S Zhang, J Wu, H Nan, L Long, J Yang, and Q Li. (2006a). Pongaflavanol-A prenylated flavonoid from Pongamia pinnata with a modified ring A. Molecules 11:786–791.
  • H Yin, S Zhang, J Wu, and H Nan. (2006b). Dihydropyranoflavones from Pongamia pinnata.. J Braz Chem Soc 17:1432–1435.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.